MEET THE FOUNDERS
Chris Corless MD PhD
Chris is currently the head of Knight Diagnostic Labs at OHSU.
He leads the clinical Precision Medicine operation at OHSU and software development for clinical decision support.
Ganapati ‘Gans’ Srinivasa
Gans previously was a Senior Principal Engineer and the Chief Architect of several generations of multi-core Xeon processors at Intel Corp. At Intel, he spearheaded the Intel-OHSU Collaborative Cancer Cloud, a federated cloud platform for cancer research. He also holds over 30 patents to his name.
Kemal Sonmez PhD
Kemal has 20 years of computational modeling and machine learning experience at SRI International and OHSU. Recently he was the technical lead for the Intel-OHSU Collaborative Cancer Cloud and now leads the early detection computational effort at the OHSU Knight Cancer Institute.
Andrew ‘Drew’ E. Senyei, MD
Dr. Senyei is a venture capitalist and inventor with more than 30 years of experience in the building of emerging technology and healthcare companies. Dr. Senyei served as Managing Director of Enterprise Partners Venture Capital with $1.1B under management for 25 years. He has served on the boards of more than 30 private and public companies and was named one of the top 100 venture capitalists in the U.S. on Forbes magazine’s 2006 Midas Touch List.
Lincoln Stein, MD PhD
Dr. Lincoln Stein is Head, Adaptive Oncology at OICR. Dr. Stein is the Program Director, Informatics and Bio-Computing, at the Ontario Institute for Cancer Research (OICR), where he is responsible for the management and analysis of large integrative cancer research projects including the International Cancer Genome Consortium (ICGC) and its Data Coordination Centre, which is hosted at OICR.
Dileep Bhandarkar PhD
Dr. Dileep Bhandarkar is President of a consulting services company called Dileep Neural Network, Inc. He was Vice President, Technology at Qualcomm Datacenter Technologies, where he worked on next-generation server platforms and deep learning accelerators.